Skip to main content

Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets

Abstract

The purpose of this research was to mask the intensely bitter taste of ondansetron HCl and to formulate a rapiddisintegrating tablet (RDT) of the taste-maske drug. Taste masking was done by complexing ondansetron HCl with aminoalkyl methacrylate copolymer (Eudragit EPO) in different ratios by the precipitation method. Drug-polymer complexes (DPCs) were tested for drug content, in vitro taste in simulated salivary fluid (SSF) of pH 6.2, and molecular property. Complex that did not release drug in SSF was considered taste-masked and selected for formulation RDTs. The complex with drug-polymer ratio of 8∶2 did not show drug release in SSF; therefore, it was selected. The properties of tablets such as tensile strength, wetting time, water absorption ratio, in vitro disintegration time, and disintegration in the oral cavity were investigated to elucidate the wetting and disintegration characteristics of tablets. Polyplasdone XL-10 7% wt/wt gave the minimum disintegration time. Tablets of batch F4 containing spray-dried mannitol and microcrystalline cellulose in the ratio 1∶1 and 7% wt/wt Polyplasdone XL-10 showed faster disintegration, within 12.5 seconds, than the marketed tablet (112 seconds). Good correlation between in vitro disintegration behavior and in the oral cavity was recognized. Taste evaluation of RDT in human volunteers revealed considerable taste masking with the degree of bitterness below threshold value (0.5) ultimately reaching to 0 within 15 minutes, whereas ondansetron HCl was rated intensely bitter with a score of 3 for 10 minutes. Tablets of batch F4 also revealed rapid drug release (t90, 60 seconds) in SGF compared with marketed formulation (t90, 240 seconds;P<.01). Thus, results conclusively demonstrated successful masking of taste and rapid disintegration of the formulated tablets in the oral cavity.

This is a preview of subscription content, access via your institution.

References

  1. Hanawa T, Watanabe A, Tsuchiya T, Ikoma R, Hidaka M, Sugihara M. New oral dosage form for elderly patients: preparation and characterization of silk fibroin gel.Chem Pharm Bull (Tokyo). 1995;43:284–288.

    CAS  Google Scholar 

  2. Ishikawa T, Watanabe Y, Utoguchi N, Matsumoto M. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter taste masked granules by compression methodChem Pharm Bull (Tokyo). 1999;47:1451–1454.

    CAS  Google Scholar 

  3. Koizumi K, Watanabe Y, Morita K, Utoguchi N, Matsumoto M. New method for preparing high porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material.Int J Pharm. 1997;152:127–131.

    Article  CAS  Google Scholar 

  4. Kaushik D, Dureja H, Saini TR. Mouth dissolving tablets: A review.Indian Drugs-Bombay. 2004;41:187–193.

    Google Scholar 

  5. Chue P, Welch R, Binder C. Acceptability and disintegration rates of orally disintegrating risperidone tablets in patients with schizophrenia or schizoaffective disorders.Can J Psychiatry. 2004;49:701–703.

    Google Scholar 

  6. Shu T, Suzuki H, Hironaka K, Ito K. Studies of rapidly disintegrating tablets in oral cavity using coground mixture of mannitol with crospovidone.Chem Pharm Bull (Tokyo). 2002;50:193–198.

    Article  CAS  Google Scholar 

  7. Seager H. Drug delivery products and the zydis fast dissolving dosage form.J Pharm Pharmacol. 1998;50:375–378.

    CAS  Google Scholar 

  8. Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique.AAPS PharmSciTech. 2004;5:E36.

    Article  Google Scholar 

  9. Chang RK, Guo X, Burnside BA, Couch RA. Fast dissolving tablets.Pharm Technol. 2000;24:52–58.

    CAS  Google Scholar 

  10. Shimizu T, Sugaya M, Nakano Y, et al. Formulation study for lansoprazol fast disintegrating tablet, III. Design of rapidly disintegrating tablets.Chem Pharm Bull (Tokyo). 2003;51:1121–1127.

    Article  CAS  Google Scholar 

  11. Thomson Micromedex Healthcare. Ondansetron hydrochloride (systemic). In:Drug Information for Health Care Professionals: USP DI. Greenwood Village, CO: Micromedex Thomson Healthcare; 2001;2248–2250.

    Google Scholar 

  12. Johnson BA, Roache JD, Javors MA, et al. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients.JAMA. 2000;284:963–971.

    Article  CAS  Google Scholar 

  13. Reddy LH, Gosh BR. Fast dissolving drug delivery system: A Review of the literature.Indian J Pharm Sci. 2002;64:331–336.

    CAS  Google Scholar 

  14. Patel DM, Patel NM, Shah RR, Jogani PL, Balapatel AI. Studies in formulation of orodispersible tablets of rofecoxib.Indian J Pharm Sci. 2004;66:621–625.

    CAS  Google Scholar 

  15. United States Pharmacopeia 24/NF 19. The Official Compendia of Standards. Asian ed. Rockville, MD: United States Pharmacopoeial Convention Inc; 2000:1913–1914.

    Google Scholar 

  16. Kuchekar BS, Badhan AC, Mahajan HS. Mouth dissolving tablets of salbutamol sulphate: a novel drug delivery system.Indian Drugs. 2004;41:592–598.

    Google Scholar 

  17. Morita Y, Tsushima Y, Termoz R, Ajioka J, Takayama K. Evaluation of disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera.Chem Pharm Bull (Tokyo). 2002;50:1181–1186.

    Article  CAS  Google Scholar 

  18. Watanabe Y, Yamamoti Y, Fujii M, Kondoh M, Shibata Y. A novel method for predicting disintegration time in the mouth of rapid disintegrating tablet by compaction analysis using Tab AII.Chem Pharm Bull (Tokyo). 2004;52:1394–1395.

    Article  Google Scholar 

  19. Narazaki R, Harada T, Takami N, Koto Y, Ohwaki T. A new method for disintegration studies of rapid disintegrating tablets.Chem Pharm Bull (Tokyo). 2004;52:704–707.

    Article  CAS  Google Scholar 

  20. Watanabe Y, Ishikawa T, Mukai B, et al. Preparation of RDT using new type of microcrystalline cellulose (PH M series) and low substituted hydroxy propyl cellulose or spherical sugar granules by direct compression method.Chem Pharm Bull (Tokyo). 2001;49: 134–139.

    Article  Google Scholar 

  21. Uchida T, Nakamura T, Tanigake A, et al. The effect of various substances on the suppression of the bitterness of quinine-human gustatory sensation, binding, and taste sensor studies.Chem Pharm Bull (Tokyo). 2002;50:1589–1593.

    Article  Google Scholar 

  22. Borodkin N, Sundberg DP. Polycarboxylic acid ion exchange resin adsorbates for taste coverage in chewable tablets.J Pharm Sci. 1971;60:1523–1527.

    Article  CAS  Google Scholar 

  23. Fernandes CM, Veiga FJ. Effect of hydrophobic nature of triacetyl-β-cyclodextrin on the complexation with nicardipine hydrochloride: physicochemical and dissolution properties of the kneaded and spray-dried complexes.Chem Pharm Bull (Tokyo). 2002;50:1597–1602.

    Article  CAS  Google Scholar 

  24. Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets.Eur J Pharm Sci. 2002;15:295–305.

    Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Shagufta Khan.

Additional information

Published: June 22, 2007

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Khan, S., Kataria, P., Nakhat, P. et al. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets. AAPS PharmSciTech 8, E127–E133 (2007). https://doi.org/10.1208/pt0802046

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1208/pt0802046

Keywords

  • Taste masking
  • rapid-disintegrating tablets
  • ondansetron HCl
  • Eudragit EPO
  • superdisintegrants